Alzheimer's

Washington D.C., Nov. 4, 2024 – Global Alzheimer’s Platform Foundation® (GAP) applauds Eisai and Biogen on the completion of the rolling submission of the application to the U.S. Food and Drug Administration (FDA) for the subcutaneous maintenance dosing of Leqembi. If approved, this autoinjector could greatly improve the patient experience, reducing the need for biweekly one-hour visits […]

Contify Life Science News Nov 3 • 11:52 PM *Cognivue’s participation in the study will help predict underlying AD pathologies and analyze MRI, neuroinflammation, and longitudinal data. Oct. 30– Cognivue issued the following news release:. Its proven ability to distinguish between cognitively normal individuals, those with MCI, and mild dementia— regardless of amyloid status., Validated […]

By Robbie Owens, November 1, 2024 / 6:05 PM CDT / CBS Texas DALLAS – If you dare, just look at the numbers associated with Alzheimer’s: nearly 7 million Americans are diagnosed with the disease right now. According to the Alzheimer’s Association, the potential lifetime impact is 1 in 3. Gail Youngdale is one of them. “My mother […]

Oct 30, 2024 | staff reporterSave for later NEW YORK – The Global Alzheimer’s Platform (GAP) Foundation has launched the Bio-Hermes-002 study, in which it will continue to explore biomarkers that can predict the likelihood that a patient has amyloid and tau accumulations in their brains, signaling a potential Alzheimer’s diagnosis. The Alzheimer’s research-focused nonprofit announced the […]

Global Alzheimer’s Platform Foundation Announces Strategic Partnerships for the Transformative Bio-Hermes-002 Study   Washington D.C., Oct. 28, 2024 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome the initial strategic partners in the Bio-Hermes-002 study. These collaborations will enhance the unique, observational platform study that compares blood-based and digital biomarkers across a broad range […]

2024, 10-21, Jason Shafrin That is the title of an interesting panel from USC Schaeffer Center on Coverage with Evidence Development (CED). It includes an interview with Tamara Syrek Jensen, Director, of the Coverage & Analysis Group within the Centers for Medicare & Medicaid Services. After the interview, there is a panel discussion of academics with […]

What we do Dementia and Neurodegeneration was identified as one of the key healthcare missions in the 2021 Life Sciences Vision. Dementia is the leading cause of death in England and one in two people will be directly affected by it – either they will care for someone with the condition, develop it themselves, or both. […]

Canton Repository The North Canton-based Ohio Center for Hope, in collaboration with Neuro-Behavioral Clinical Research, played host to a highly successful Memory Day + Senior Resource Fair on Sept. 14 at Firestone Park Community Center. The event provided free memory screenings, emphasized the critical importance of early memory-loss detection, provided valuable information for those experiencing […]

By Raya Torres, Published: Sep. 18, 2024 at 3:01 PM EDT TUCSON, Ariz. (13 News)—The Banner Alzheimer’s Institute hosted a senior health resource fair on Tuesday, Sept. 17, to increase awareness of brain health and Alzheimer’s prevention and awareness. According to the National Council on Aging, Latinos maybe 50% more likely to develop Alzheimer’s, but they are […]

By Axiom Brain Health We have all heard how important it is to eat well, exercise, and get enough sleep for good health, but did you know that there are additional ways you may improve your brain health? Learn about three unique ways you may reduce the risk of memory loss and/or may prevent the onset […]

September 05, 2024 6:14 PM in Noticias RGV, By: Santiago CaicedoUn centro de investigación del Alzheimer’s busca personas para dos nuevos estudios, quieren frenar o curar enfermedades como la demencia. Priscilla Sánchez, queda con los buenos recuerdos de su abuelo Roel Sánchez. “Las veces que preguntaba por su esposa que ya no estaba, esas eran las partes que […]

by Zoe Holman, Fri, August 16th 2024 at 5:24 PM A global Alzheimer’s organization is expanding its research into southeast Texas. The global Alzheimer’s Platform Foundation is partnering with Gadolin Research. The Beaumont Medical Clinic joins more than 130 research centers worldwide that make up the G.A.P. network. The joint partnership centered on improving access to […]

An eye-based Alzheimer’s disease test Routine eye exams could provide data to identify a patient’s disease risk earlier Spotted: Dementia diagnoses appear to be increasing worldwide, most likely from a combination of ageing populations and improved awareness of the disease alongside strengthened diagnostic tools. In Canada, medical AI company RetiSpec uses commonly used eye exam images to diagnose Alzheimer’s […]

NEWS PROVIDED BYiLoF , Jul 31, 2024, 09:28 ET The international clinical study, Bio-Hermes-002, establishes an ambitious transnational collaboration aimed at achieving a breakthrough in Alzheimer’s diagnosis and treatment. LONDON and ROCHESTER, N.Y., July 31, 2024 /PRNewswire/ — iLoF, a global deep tech digital health company, today announced it has secured a £1.2M (~$1.5M) clinical research contract from Innovate UK, […]

By Jordan Bowen, Published  July 29, 2024 10:22pm EDT Could a blood test help diagnose Alzheimer’s? A study published in the Journal of the American Medical Association found a specific blood test known as the p-tau217 can determine if someone’s memory loss issues are caused by Alzheimer’s disease. TAMPA, Fla. – It’s a fear many of us have […]

Cambridge, UK—10 July 2024: Cambridge Cognition, a leading provider of digital health solutions for brain health assessments has been included in the Bio-Hermes 2 project for its voice and touch-screen cognitive assessments, funded by the UK’s innovation agency, Innovate UK.  The Bio-Hermes 2 trial, led by the Global Alzheimer’s Platform Foundation (GAP), aims to determine […]

10 July 2024 Innovate UK has awarded four UK companies a share of £4 million funding through Contracts for Innovation to support innovative research into dementia diagnosis. The funding will enable organisations to evaluate blood-based and digital biomarkers as part of the Bio-Hermes-002 study. This international study is led by the Global Alzheimer’s Platform Foundation® […]

The Washington, D.C.-based Global Alzheimer’s Platform Foundation announced on July 8 that Snellville resident Tamiko MaGee-Rodgers has been named director of the foundation’s Recruitment and Strategic Initiatives. The nonprofit GAP was founded to speed the delivery of Alzheimer’s treatments with a commitment to promoting diversity in clinical research and lowering the cost and duration of […]

Washington D.C., July 8, 2024- Global Alzheimer’s Platform Foundation® (GAP) announced the appointment of Leigh Zisko, MPH as Chief Impact Officer and Tamiko MaGee-Rodgers, PhD, CCRP as the Director of Recruitment and Strategic Initiatives. In newly created global leadership roles, each will meaningfully contribute new perspectives and experience to GAP’s work in innovating clinical trial […]

Washington D.C., July 2, 2024- Global Alzheimer’s Platform Foundation® (GAP) President John Dwyer applauds the U.S. Food and Drug Administration (FDA) for its decision granting full traditional approval of Eli Lilly and Company’s Kisunla™ (donanemab), a disease-modifying Alzheimer’s treatment for adults with early symptomatic Alzheimer’s disease (AD).  “Today, the FDA grants full approval for donanemab, […]

Washington D.C., July 1, 2024- The Food and Drug Administration (FDA) unveiled a draft guidance document, “Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies,” which is open for public comment. This draft guidance points to improving participation from people who are traditionally underrepresented in clinical trials. John Dwyer, President […]

Resident contributor, Dr. Susan Steen breaks down three life changes to trackto prioritize your brain health as you and your loved ones age. As people age, it’s normal to experience occasional forgetfulness, however when does ‘some’ memory loss become a bigger concern? There are three aspects of your life that you can reflect on and […]

Global non-profit expands research network to the greater New Orleans areato improve access to research opportunities Washington D.C., June. 17, 2024- Global Alzheimer’s Platform Foundation® (GAP) is welcoming its first clinical research site from Louisiana into its network, Tandem Clinical Research of greater New Orleans. Tandem Clinical Research, a Prolerity Clinical Research Company site, advances […]

Washington D.C., June. 14, 2024- Global Alzheimer’s Platform Foundation® (GAP) proudly collaborated with The Global CEO Initiative on Alzheimer’s Disease (CEOi) to release the peer-reviewed publication of “Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease,” in Nature Reviews Neurology. Alzheimer’s blood tests have the […]